Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 23, 2026 09:25 ET | Source: Imunon, Inc.

IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development

Translational and clinical data reinforce IMNN-001's potential to unlock IL-12's anti-tumor power in ovarian cancer within a highly safe, proprietary mechanism First-of-its-kind meeting spotlights...
July 21, 2026 02:30 ET | Source: Enterome

Enterome Phase 2 data show EO2463-induced CD8 T-cell expansion correlates with progression-free survival in patients with indolent non-Hodgkin lymphoma in the watch-and-wait setting

Enterome Phase 2 data show EO2463-induced CD8 T-cell expansion correlates with PFS in patients with iNHL in the watch-and-wait setting
July 20, 2026 14:00 ET | Source: Deep Origin

Deep Origin's Computational Platform Rationalizes Results of Molecular Glue Compound That Potently Kills Diffuse Large B Cell Lymphoma Cells

Deep Origin today announced that its computational platform contributed to a peer-reviewed study published in Cell.
July 14, 2026 05:00 ET | Source: Hummingbird Bioscience

Hummingbird Bioscience Wins APAC Trailblazer Award at 2026 Nebius AI Discovery Awards

From 647 nominations globally, Hummingbird Bioscience emerged as a winner, recognizing the company’s AI-first approach to drug discovery and development.
July 13, 2026 04:22 ET | Source: Research and Markets

Pharmaceutical Regulatory Affairs in the Middle East and North Africa: Online Course Delivers Country-by-Country Regulatory Mastery Across the Region

Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in the Middle East and North Africa (Oct 20th - Oct 22nd, 2026)" has been added to ResearchAndMarkets.com's...
July 07, 2026 08:00 ET | Source: Certara

Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit

Certara partners with NVIDIA to advance its open, integrated AI platform for drug discovery and development with the BioNeMo Agent Toolkit
July 06, 2026 10:55 ET | Source: Research and Markets

Pharmaceutical Regulatory Affairs in Asia: Three-Day Online Course Opens Registration for October 20–22, 2026 Early-Bird Pricing Ends September 15

Dublin, July 06, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Asia (Oct 20th - Oct 22nd, 2026)" has been added to ResearchAndMarkets.com's offering. The course addresses a...
July 06, 2026 07:07 ET | Source: Pluristyx, Inc.

Pluristyx Inc. Secures Initial Close of Series A Priced Round with Multinational Fortune 500 Company; Round to Remain Open for Syndicate Partners Until September 2nd

Pluristyx secures a Series A priced round initial close led by a multinational Fortune 500 company to accelerate growth and expand its stem cell platform.
June 30, 2026 05:30 ET | Source: Salipro Biotech AB

Salipro Biotech Announces Publication in Nature Scientific Reports on Expanding DEL Screening to Membrane Proteins

Salipro Biotech and collaborators unlock DNA‑Encoded Library screening for challenging membrane protein targets, expanding drug discovery possibilities.
June 19, 2026 01:15 ET | Source: Novo Nordisk Foundation

New European initiative to accelerate drug discovery for cardiometabolic diseases

The Novo Nordisk Foundation is funding a new pan-European initiative to accelerate drug discovery for cardiometabolic diseases (CMDs).